Weihai Huayang Pharmaceutical

Weihai Huayang Pharmaceutical is a specialized pharmaceutical company based in Weihai, China, primarily focused on the development and manufacture of chemical drugs and Active Pharmaceutical Ingredients (APIs). Since its inception in 2002, the company has established a significant presence in the macrolide antibiotic market, producing key drugs such as Clarithromycin and Azithromycin. Beyond anti-infectives, its portfolio includes treatments for gastrointestinal conditions, cardiovascular diseases, and diabetes. The company operates modern, GMP-compliant manufacturing facilities and serves both the Chinese domestic market and various international regions. Weihai Huayang is recognized for its integrated approach to drug production, spanning from raw material synthesis to finished dosage forms.